The latest closing stock price for PMV Pharmaceuticals as of June 24, 2025 is 1.16.
An investor who bought $1,000 worth of PMV Pharmaceuticals stock at the IPO in 2020 would have $-969 today, roughly -1 times their original investment - a -50.10% compound annual growth rate over 5 years.
The all-time high PMV Pharmaceuticals stock closing price was 61.51 on December 31, 2020.
The PMV Pharmaceuticals 52-week high stock price is 1.82, which is 56.9% above the current share price.
The PMV Pharmaceuticals 52-week low stock price is 0.81, which is 30.2% below the current share price.
The average PMV Pharmaceuticals stock price for the last 52 weeks is 1.38.
An investor who bought $1,000 worth of PMV Pharmaceuticals stock at the IPO in 2020 would have $-969 today, roughly -1 times their original investment - a -50.10% compound annual growth rate over 5 years.
The all-time high PMV Pharmaceuticals stock closing price was 61.51 on December 31, 2020.
The PMV Pharmaceuticals 52-week high stock price is 1.82, which is 56.9% above the current share price.
The PMV Pharmaceuticals 52-week low stock price is 0.81, which is 30.2% below the current share price.
The average PMV Pharmaceuticals stock price for the last 52 weeks is 1.38.